MYF-03-176

N/A

Report date: 2023/03/24 14:48:52
NME

Base Information

Drug NameMYF-03-176
Drug Alias NameMYF-03-176
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional enhancer factor inhibitors
TargetsTranscriptional enhancer factor
Therapy Area/IndicationsMesotheliomaLiposarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer Institute
Inactive CompaniesN/A
Active IndicationsMesotheliomaLiposarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A